Korangy Appointed CEO of Fresenius Medical Care to Lead Next Phase of Strategic Development, Long-term Profitable Growth
October 08, 2026
October 08, 2026
HOMBURG, Germany, Oct. 8 -- Fresenius Medical Care, a provider of products and services for people with chronic kidney failure, issued the following news release:
* * *
Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth
Bad Homburg (October 7, 2026) - Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal disea . . .
* * *
Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth
Bad Homburg (October 7, 2026) - Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal disea . . .